A hematology drugmaker that could rise at least 60% and a gene therapy developer that could nearly double top the list of the favorite biotech stocks of a newly-hired analyst at Raymond James. Also making the list of top biotech stocks? A neurology stock, a hematology stock – and more. For a closer look at each of these biotech stocks, CLICK HERE.
Recent Posts
- “Gigantic Upside Potential”: 5 Buy-Rated, Under-$10 Stocks For Aggressive Investors
- 4 Tech Stocks To Watch As Investors Go Back To Last Year’s Playbook
- Better Know These Lesser-Known Biotech Stocks That Have Been Surging
- 5 Buy-Rated Stocks Priced Under $10 Offering Solid Alpha Potential
- “In A League Of Its Own”: This Immuno-Oncology Stock’s Great Run In 2020 May Have Just Been The Beginning
Categories
Download This Free Report
